![Rasmus Irming Jølck](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Rasmus Irming Jølck
Corporate Officer/Principal chez Nanovi Radiotherapy A/S
Profil
Rasmus Irming Jølck is currently working as a Development Director at Nanovi Radiotherapy A.
Prior to this, he worked as a Principal at Technical University of Denmark.
Postes actifs de Rasmus Irming Jølck
Sociétés | Poste | Début |
---|---|---|
Nanovi Radiotherapy A/S
![]() Nanovi Radiotherapy A/S Pharmaceuticals: MajorHealth Technology Nanovi Radiotherapy A/S provides radiotherapy related products for the treatment of cancer. Its product BioXmark is a liquid ready-to-insert fiducial marker, which once inserted into soft tissue forms a semi-solid gel. The firm's platform provides an opportunity to encapsulate chemotherapeutics within the gel. The company was founded by Thomas Lars Andresen and Morten Albrechtsen in 2012 and is headquartered in Kongens Lyngby, Denmark. | Corporate Officer/Principal | - |
Anciens postes connus de Rasmus Irming Jølck
Sociétés | Poste | Fin |
---|---|---|
Technical University of Denmark | Corporate Officer/Principal | 03/11/2014 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
Nanovi Radiotherapy A/S
![]() Nanovi Radiotherapy A/S Pharmaceuticals: MajorHealth Technology Nanovi Radiotherapy A/S provides radiotherapy related products for the treatment of cancer. Its product BioXmark is a liquid ready-to-insert fiducial marker, which once inserted into soft tissue forms a semi-solid gel. The firm's platform provides an opportunity to encapsulate chemotherapeutics within the gel. The company was founded by Thomas Lars Andresen and Morten Albrechtsen in 2012 and is headquartered in Kongens Lyngby, Denmark. | Health Technology |